NATCO Pharma informs about analyst meet

24 Feb 2025 Evaluate

NATCO Pharma has informed that it enclosed the disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the information that the officials of the Company will be participating in meeting with investor ‘BoB Capital Markets’ (In-person) on 28th February 2025 at 3:30 pm at Hyderabad. No Unpublished price Sensitive Information (UPSI) is intended to be discussed during the interactions.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

797.70 -24.70 (-3.00%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...